PLURISTEM THERAPEUTICS INC - COM (PSTI)

CUSIP: 72940R102

Q2 2018 13F Holders as of 30 Jun 2018

Type / Class
Equity / COM
Total 13F shares
4,002,896
Share change
-382,527
Total reported value
$4,878,488
Put/Call ratio
0%
Price per share
$1.22
Number of holders
33
Value change
-$630,782
Number of buys
19
Number of sells
10

Quarterly Holders Quick Answers

What is CUSIP 72940R102?
CUSIP 72940R102 identifies PSTI - PLURISTEM THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of PLURISTEM THERAPEUTICS INC - COM (PSTI) as of Q2 2018

As of 30 Jun 2018, PLURISTEM THERAPEUTICS INC - COM (PSTI) was held by 33 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 4,002,896 shares. The largest 10 holders included ARK Investment Management LLC, RENAISSANCE TECHNOLOGIES LLC, CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM, UBS Group AG, Psagot Investment House Ltd., GEODE CAPITAL MANAGEMENT, LLC, RAYMOND JAMES & ASSOCIATES, Harel Insurance Investments & Financial Services Ltd., HighTower Advisors, LLC, and HERITAGE INVESTORS MANAGEMENT CORP. This page lists 33 institutional shareholders reporting positions in this security for the Q2 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.